Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center